GWO XI STEM CELL APPLIED TECHNOLOGY CO. , LTD

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704

TW0006704000

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
38.15 ^TWD	-0.78%		-2.80%	+5.10%

Apr. 25	Gwo Xi Stem Cell Applied Technology Co. , Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Gwo Xi Stem Cell Applied Technology Co. , Ltd(TPEX:6704) added to S&P Global BMI Index	CI

Gwo Xi Stem Cell Applied Technology Co. , Ltd(TPEX:6704) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Gwo Xi Stem Cell Applied Technology Co. , Ltd(TPEX:6704) added to S&P Global BMI Index	23-09-18	CI

Chart Gwo Xi Stem Cell Applied Technology Co. , Ltd

Duration

Period

Chart Gwo Xi Stem Cell Applied Technology Co. , Ltd

More charts

Gwo Xi Stem Cell Applied Technology Co Ltd is a Taiwan-based company mainly engaged in the development of stem cell drugs and technologies for the treatment of refractory diseases. The Company owns the Medical-Grade Cell Preparation Platform for the collection, isolation, culture, scaling up, packaging, testing, transportation, storage and treatment of human stem cells. The platform is modularized to create the stem cell activation technology Nigiro-Med, medical grade stem cell storage service and clinical cell preparation quality testing service. The Company operates through Stem Cell Freezing segment, Health Care Products and Maintenance Products segment, and Other segment.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GWO XI STEM CELL APPLIED TECHNOLOGY CO. , LTD	+5.10%	113M
ELI LILLY AND COMPANY	+48.39%	765B
JOHNSON & JOHNSON	-6.13%	354B
MERCK & CO., INC.	+20.61%	331B
ABBVIE INC.	+10.00%	299B
ASTRAZENECA PLC	+18.87%	248B
ROCHE HOLDING AG	-1.96%	219B
NOVARTIS AG	+11.11%	216B
AMGEN INC.	+5.80%	164B
PFIZER, INC.	-2.50%	162B